CASSOVIAPHARM, s.r.o.Active
Key figures
Key figures
2025Dividends
calculatedNo dividends were distributed.
Balance sheet structure
Summary of annual reports2020–2025
| 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Revenue (net turnover) | 0 | 0 | 0 | 2 350 | 0 |
| Profit for the reporting year | -5 387 | -412 | 19 659 | 1 772 | -524 |
| Retained earnings of previous periods | 176 491 | 27 340 | 26 928 | 3 787 | 5 559 |
| Total assets | 186 838 | 36 235 | 57 584 | 13 302 | 12 778 |
| Total liabilities | 8 431 | 2 004 | 3 694 | 440 | 440 |
| Total equity | 178 407 | 34 231 | 53 890 | 12 862 | 12 338 |
| Calculated dividends | 103 229 | 143 764 | 0 | 42 800 | 0 |
A dash (—) means the report has not been filed or the line is not reported; 0 is a zero stated in the report.
Summary: CASSOVIAPHARM, s.r.o.
Overview
CASSOVIAPHARM, s.r.o. (IČO 36729353) is a limited liability company (s.r.o.). The company was incorporated in 2007 and has existed for 19 years. Registered office according to the register: Košice - mestská časť Šaca. Main activity according to the Statistical Office: maloobchod s farmaceutickými výrobkami (SK NACE 4773).
People
The company has one statutory representative. According to the register, the company has 2 shareholders. The registered capital is 6 640 €.
Financial results
The company reported no revenue in 2025. 2025 ended with a loss of 524 €. The company was profitable in 2 of the 6 reported years. At the end of 2025 the company had total assets of 12 778 € and equity of 12 338 € (equity ratio 96,6 %).
Sources and freshness
Company and people data come from the Register of Legal Entities (Statistical Office SR, CC BY 4.0) and financial statements from the Register of Financial Statements (Ministry of Finance SR); icoprofil.sk updates them daily. Data as of 7. 11. 2026. Changes, averages and ratios are calculated by icoprofil.sk from open data and are not an official assessment.